| 1. |
Managing albuminuria in patients with diabetes |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1114KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 2. |
Clash of opinions in calcium antagonist controversy |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 3-4
Sean Henahan,
Preview
|
PDF (2348KB)
|
|
摘要:
The ongoing debate on the efficacy and tolerability of calcium antagonists in patients with cardiovascular disease was in the spotlight at the recent meeting of the 68th Scientific Sessions of the American Heart Association [AHA;Anaheim, US; November 1995]. Leading researchers entered into a heated debate on the mortality risk associated with the use of these agents, a subject which was set in motion by a case-controlled study.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 3. |
Fluoxetine cheapest SSRI, but is it worth it? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 4-4
&NA;,
Preview
|
PDF (1074KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 5-5
&NA;,
Preview
|
PDF (1111KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 5. |
Economic grounds for CF carrier screening programme |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 6-6
&NA;,
Preview
|
PDF (1063KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 6. |
Is screening to prevent diabetic nephropathy cost effective? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 7-7
&NA;,
Preview
|
PDF (1084KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 7. |
Inhibiting heparanase could lead to new indications for heparin |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 8-9
Gill Higgins,
Preview
|
PDF (2207KB)
|
|
摘要:
A novel approach to treating conditions that involve excessive cell growth has been identified. The pivotal factor has been the characterisation of a mammalian heparanase, which is now known to be the chemokine CTAP-III. At an IBC USA conference on Chemotactic Cytokines [Philadelphia, US; October 1995], Dr Steven Ledbetter from Upjohn, Kalamazoo, US, described recent data on this enzyme and its effects on heparan sulfate proteoglycans. Other research has suggested that it may be possible to use certain heparins to treat conditions such as cancer and arthritis via heparanase inhibition.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 8. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 9-9
&NA;,
Preview
|
PDF (1047KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 9. |
Achieving the best response to radiotherapy in cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 10-11
Gill Higgins,
Preview
|
PDF (2111KB)
|
|
摘要:
The efficacy of radiotherapy in patients with cancer is thought to be limited by the presence of hypoxic cells in tumour tissue. Of the various strategies that have been used to overcome this problem, bioreductive drug treatment appears to be one of the most promising. The use of interferon-&bgr; as a radiosensitiser also appears to have potential, according to the results of a study in patients with solid tumours, which was presented at the 8th European Cancer Conference [ECCO 8;Paris, France; October/November 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 10. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1018,
1995,
Page 11-11
&NA;,
Preview
|
PDF (1027KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
首页
